Rentokil Initial PLC (RTO)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 339.00 |
|---|---|
| 52-week range | 293.50 – 507.00 |
| Return, 1 month / 3 months | +4.9% / −20.3% |
| Return, 1 year / 3 years | −21.5% / −21.5% |
| Trend | Below its 200-day average |
| RSI (14) | 69 |
| Volatility (1 year) | 35.1% |
| Worst drawdown (1 year) | -41.0% |
| Average daily value traded | 3,969.18M GBX |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Rentokil Initial is a services company based in the United Kingdom that focuses on pest control and hygiene. It helps businesses and households deal with rodents, insects and other pests, and it supplies washroom hygiene products and services such as hand care, air care and specialist cleaning. The company also provides textile and workwear services. Its customers range from offices, restaurants and hospitals to factories and private homes, and it operates through local branches in many countries.
The shares are listed on the London Exchange in UK under the code RTO, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Rentokil Initial PLC (RTO) trades on the London Exchange in UK. It last closed at GBX 339.00 on 23 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 2,778 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.5% and over the last three months it fell 20.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 17 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.8% | ||
| From 52-week high | -33.1% | ||
| Momentum | 13 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.3% | ||
| 6-month return | -30.7% | ||
| 12-month return, skipping the last month | -25.2% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -41.0% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 3,969.18M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 44 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +7.3% |
|---|---|
| 1 month | +4.9% |
| 3 months | −20.3% |
| 6 months | −30.7% |
| 1 year | −21.5% |
| 3 years | −21.5% |
| 5 years | −37.9% |
Signals
| 50-day / 200-day average | 325.43 / 417.38 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 8.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.0329 |
| 9 Apr 2026 | GBP 0.0610 |
| 14 Aug 2025 | GBP 0.0308 |
| 3 Apr 2025 | GBP 0.0593 |
| 8 Aug 2024 | GBP 0.0316 |
| 4 Apr 2024 | GBP 0.0593 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.